Total Payments
$2,845
2024 Payments
$84.94
Companies
23
Transactions
44
Medicare Patients
1,869
Medicare Billing
$236,522
Payment Breakdown by Category
Consulting$1,665 (58.5%)
Food & Beverage$954.86 (33.6%)
Other$150.00 (5.3%)
Education$50.16 (1.8%)
Gifts$25.00 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,665 | 1 | 58.5% |
| Food and Beverage | $954.86 | 38 | 33.6% |
| Honoraria | $150.00 | 1 | 5.3% |
| Education | $50.16 | 3 | 1.8% |
| Gift | $25.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,721 | 3 | $0 (2024) |
| Amgen Inc. | $192.18 | 9 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $150.00 | 1 | $0 (2021) |
| Galvanize Therapeutics, Inc | $113.12 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $92.11 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $89.26 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $70.18 | 4 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $51.37 | 2 | $0 (2018) |
| Lilly USA, LLC | $41.13 | 2 | $0 (2018) |
| Channel Medsystems, Inc. | $38.15 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.94 | 3 | Channel Medsystems, Inc. ($38.15) |
| 2023 | $127.49 | 2 | Galvanize Therapeutics, Inc ($113.12) |
| 2022 | $30.00 | 1 | AstraZeneca Pharmaceuticals LP ($30.00) |
| 2021 | $1,827 | 3 | AstraZeneca Pharmaceuticals LP ($1,665) |
| 2019 | $65.04 | 4 | Tosoh Bioscience, Inc. ($25.00) |
| 2018 | $365.50 | 13 | Amgen Inc. ($114.10) |
| 2017 | $345.13 | 18 | Amgen Inc. ($78.08) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 11/18/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2024 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $38.15 | General |
| 08/14/2023 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $113.12 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 01/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Obesity | ||||||
| 12/09/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/24/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,665.00 | General |
| 02/23/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Honoraria | Cash or cash equivalent | $150.00 | General |
| Category: Immunology | ||||||
| 05/20/2019 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2019 | Tosoh Bioscience, Inc. | G8 Elution Buffer No. 1, 800mL (Medical Supply), G8 elution Buffer No. 2, 800mL, G8 Elution Buffer No. 3, 800mL | Gift | In-kind items and services | $25.00 | General |
| Category: Hematology | ||||||
| 04/15/2019 | Array BioPharma Inc. | Braftovi (Drug), Mektovi | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Melanoma | ||||||
| 01/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $77.14 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 09/11/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.55 | General |
| 06/12/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Oncology | ||||||
| 06/04/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $89.26 | General |
| Category: Oncology | ||||||
| 05/08/2018 | Lilly USA, LLC | ALIMTA (Drug), ERBITUX | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Oncology | ||||||
| 04/10/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Oncology | ||||||
| 03/27/2018 | Amgen Inc. | Aranesp (Biological), Nplate, Prolia | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Nephrology | ||||||
| 03/20/2018 | Amgen Inc. | Neulasta (Biological), Vectibix, XGEVA | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Oncology | ||||||
| 02/13/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Oncology | ||||||
| 01/23/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 446 | 664 | $171,273 | $62,413 |
| 2022 | 7 | 439 | 645 | $147,154 | $58,855 |
| 2021 | 8 | 483 | 688 | $149,842 | $65,095 |
| 2020 | 8 | 501 | 722 | $130,839 | $50,160 |
Total Patients
1,869
Total Services
2,719
Medicare Billing
$236,522
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 312 | $75,816 | $26,523 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 101 | $34,643 | $13,006 | 37.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 61 | 61 | $25,681 | $9,884 | 38.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 73 | $10,001 | $4,242 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 73 | $12,556 | $4,092 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,360 | $2,350 | 37.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 24 | $6,216 | $2,316 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 288 | $61,497 | $23,665 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 67 | 131 | $38,633 | $17,022 | 44.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $10,827 | $4,459 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 78 | $11,526 | $4,159 | 36.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 65 | $8,991 | $3,561 | 39.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 35 | $9,146 | $3,427 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,534 | $2,562 | 39.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 85 | 180 | $49,140 | $23,977 | 48.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 205 | $41,410 | $17,986 | 43.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 40 | 40 | $15,640 | $6,192 | 39.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 96 | $13,152 | $5,147 | 39.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 82 | $11,398 | $4,578 | 40.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 31 | 32 | $8,384 | $3,379 | 40.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $5,890 | $2,201 | 37.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 29 | 34 | $4,828 | $1,636 | 33.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 196 | $39,592 | $14,850 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 174 | 224 | $30,688 | $11,038 | 36.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 55 | 55 | $17,050 | $6,732 | 39.5% |
About Dr. Amy Schell, M.D
Dr. Amy Schell, M.D is a Hematology & Oncology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437265436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Schell, M.D has received a total of $2,845 in payments from pharmaceutical and medical device companies, with $84.94 received in 2024. These payments were reported across 44 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($1,665).
As a Medicare-enrolled provider, Schell has provided services to 1,869 Medicare beneficiaries, totaling 2,719 services with total Medicare billing of $236,522. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Lexington, KY
- Active Since 08/22/2006
- Last Updated 12/02/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1437265436
Products in Payments
- Soliris (Drug) $150.00
- Kyprolis (Biological) $114.05
- ALIYA SYSTEM (Device) $113.12
- GILOTRIF (Drug) $92.11
- OPDIVO (Biological) $89.26
- XARELTO (Drug) $51.37
- DARZALEX (Biological) $48.27
- Aranesp (Biological) $45.15
- ALIMTA (Drug) $41.13
- Venclexta (Drug) $32.58
- Abraxane (Drug) $27.35
- ALOXI (Drug) $26.09
- ENHERTU (Biological) $25.95
- G8 Elution Buffer No. 1, 800mL (Medical Supply) $25.00
- Braftovi (Drug) $22.49
- Nplate (Biological) $22.39
- IMBRUVICA (Drug) $21.91
- INLYTA (Drug) $20.84
- Imbruvica (Drug) $19.16
- TASIGNA (Drug) $17.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lexington
Dr. Nicola Jabbour, M.d, M.D
Hematology & Oncology — Payments: $611,455
Hematology & Oncology $611,455
Dr. Lowell Anthony, M.d, M.D
Hematology & Oncology — Payments: $64,060
Hematology & Oncology $64,060
Dr. Zhonglin Hao, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $22,675
Hematology & Oncology $22,675
John Villano
Hematology & Oncology — Payments: $17,051
Hematology & Oncology $17,051
Dr. Jessica Croley, Md, MD
Hematology & Oncology — Payments: $13,189
Hematology & Oncology $13,189
Mr. Russell Eldridge, Md, MD
Hematology & Oncology — Payments: $10,781
Hematology & Oncology $10,781